Signaling Pathways
Product Name | CAS No. | Specification | Application | Registration |
Roflumilast | 162401-32-3 | 99+% | ||
Methotrexate | 59-05-2 | 99+% | ||
G-418 Disulfate | 108321-42-2 | 98+% | ||
Vinpocetine | 42971-09-5 | 98+% | ||
Procainamide Hydrochloride | 614-39-1 | 98+% | ||
Dapoxetine Hydrochloride | 129938-20-1 | 98+% | ||
Sunitinib Malate | 341031-54-7 | 98+% | ||
Cetilistat (ATL-962) | 282526-98-1 | 98+% | ||
Saxagliptin hydrate (BMS-477118 hydrate) | 945667-22-1 | 98+% | ||
Dirithromycin | 62013-04-1 | 98+% | ||
Guanine | 73-40-5 | 98+% | ||
Sorafenib Tosylate | 475207-59-1 | 99+% | ||
Rapamycin (Sirolimus) | 53123-88-9 | 98+% | ||
Tobramycin | 32986-56-4 | 900μg/mg+ | ||
Tobramycin Sulfate | 79645-27-5 | 634 to 739μg/mg |
Products
- All
- Pharmaceutical Intermediates
- Active Pharmaceutical Ingredients
- Drug Impurities & Metabolites
- Novel Life Science Reagents
- Signaling Pathways
- Inhibitory Antibodies
- Bioactive Small Molecules
- Screening Compounds
- Stable Isotope Labelled Compounds
- COVID-19 Related Inhibitors
- Amino Acids & Vitamins
- Natural Products
- Health & Nutritional Ingredients
- Pharmaceutical Excipients
- Specialty Chemicals & Building Blocks